Out of these 24 patients with more than one TET2 variants 15 patients exhibit a CMML disease (remaining 9 patients show 2nd AML, RCMD, MDS-unclassifiable, and MDS/MPN-unclassifiable, respectively). This evidence concerns the gene TET2 and chronic myelomonocytic leukemia.